Garmin Venu 2 Plus ECG App unlocks long-awaited function in the United States
Garmin has announced that the US Food and Drug Administration (FDA) has finally given its ECG App for the Venu 2 Plus a go. Therefore, its units in this country can now use the electrocardiography hardware found in their wearable for the first time. Users can view their "revolutionary" cardiac graphs right on their wrist or sync them to the Connect smartphone app.
That may be part of the reason Garmin touted the Venu 2 Plus as an ECG-capable smartwatch on its launch; however, it required FDA approval prior to its activation.
Now, having secured that clearance, the OEM has unveiled its ECG App, the UI by which the Venu 2 Plus can use its cutting-edge function.
It can be used to record 30-second cardiograms and visualize them on the watch instantaneously, or sync them to their mobile device through Garmin Connect.
The OEM asserts that its new ECG App is capable of detecting atrial fibrillation (AFib) as well as offer a new kind of health-tracking in general.
Garmin does not go so far as to describe the Venu 2 Plus as a clinical device now, but does suggest that a user can gather ECG App data to help keep their doctor updated on their health status. It is available from now as a part of the wearable's v.11.21 software update.
Deirdre O'Donnell - Senior Tech Writer - 5992 articles published on Notebookcheck since 2018
I became a professional writer and editor shortly after graduation. My degrees are in biomedical sciences; however, they led to some experience in the biotech area, which convinced me of its potential to revolutionize our health, environment and lives in general. This developed into an all-consuming interest in more aspects of tech over time: I can never write enough on the latest electronics, gadgets and innovations. My other interests include imaging, astronomy, and streaming all the things. Oh, and coffee.